For Q1 FY2026 ended March 31, 2026, Vireo Growth Inc. reported revenue of $106.2 million, a 333.5% increase year-over-year. Operating income was $9.0 million, up 350% from the prior year. However, net loss widened to $20.3 million from a loss of $6.5 million in the same quarter last year. Cash and cash equivalents stood at $122.4 million, with total equity of $294.1 million.
•Revenue surged 333.5% YoY to $106.2 million.
•Operating income rose 350% YoY to $9.0 million.
•Net loss increased to $20.3 million from $6.5 million in Q1 FY2025.
•Cash balance was $122.4 million as of March 31, 2026.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
Vireo Growth is a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah.
It sells cannabis products through a network of retail dispensaries and distributors. Incorporated in 2004 and headquartered in Minneapolis, Minnesota, Vireo Growth was formerly known as Goodness Growth Holdings, Inc. before rebranding in July 2024.
Vireo Growth Inc. is a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It operates in six U.S. states: Maryland, Minnesota, Missouri, Nevada, New York, and Utah. The company sells its cannabis products through a network of retail dispensaries and distributors. Formerly known as Goodness Growth Holdings, Inc., it rebranded to Vireo Growth in July 2024. The company is headquartered in Minneapolis, Minnesota, and was incorporated in 2004.
Where is Vireo Growth Inc. (VREOF) listed and in what currency?
Vireo Growth Inc. trades on the OTC Markets OTCPK exchange under the ticker symbol VREOF. Its financials are reported in U.S. dollars (USD), as the company is based in the United States. The OTC Markets exchange is an over-the-counter marketplace where stocks that do not meet the listing requirements of major exchanges like the NYSE or Nasdaq are traded.
What sector and industry does Vireo Growth Inc. operate in?
Vireo Growth Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. As a cannabis company, it focuses on the production and distribution of medical and adult-use cannabis products. This industry classification reflects its role in manufacturing specialty pharmaceutical and generic-type products derived from cannabis.
Where is Vireo Growth Inc. headquartered and what markets does it serve?
Vireo Growth Inc. is headquartered in Minneapolis, Minnesota, United States. It serves medical and adult-use cannabis markets in six states: Maryland, Minnesota, Missouri, Nevada, New York, and Utah. The company cultivates, manufactures, processes, and distributes cannabis products within these states, operating through a network of retail dispensaries and distributors.
How does Vireo Growth Inc. make money?
Vireo Growth Inc. generates revenue by cultivating, manufacturing, processing, and distributing medical and adult-use cannabis products. It sells these products through its own network of retail dispensaries and through third-party distributors. The company operates in six U.S. states, each with its own regulatory framework for cannabis sales. Its business model encompasses the entire supply chain from cultivation to retail, allowing it to capture value at multiple stages.